Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report-Reference-Cited by-同舟云学术

Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report

Published:2023-11-22 Issue:1 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Guo Tianhao¹,Zhu Wenjian²,Zhao Shuoqi²,Qiu Wenli³,Wu Yan⁴,Li Xuan⁴,Ke Fei⁵,Cheng Haibo²

Affiliation:

1. Institute of Health and Regimen, Jiangsu Open University, Nanjing, Jiangsu 210036, P.R. China

2. Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, Jiangsu 210023, P.R. China

3. Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China

4. Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China

5. Department of Pathology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference34 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023

3. Clinical relevance of targeted therapy and immune-checkpoint inhibition in lung cancer;Leone;Pharmaceutics,2023

4. EGFR polymorphism and survival of NSCLC patients treated with TKIs: A systematic review and meta-analysis;Jurisic;J Oncol,2020

5. Side effects of tyrosine kinase inhibitors therapy in patients with non-small cell lung cancer and associations with EGFR polymorphisms: A systematic review and meta-analysis;Obradovic;Oncol Lett,2022